Jazz Pharmaceuticals plc Current Assets
Jazz Pharmaceuticals plc (JAZZ) had Current Assets of $3.97 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-03
- 2026-06-30: Assets, Current $3.97B.
- 2026-03-31: Assets, Current $4.58B.
- 2025-12-31: Assets, Current $4.17B; Assets, Current as first filed $4.17B.
- 2025-09-30: Assets, Current $3.76B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.97B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $4.58B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $4.17B 10-Q · filed 2026-08-03 | $4.17B 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.76B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.35B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $4.13B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $4.63B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $4.39B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.68B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $3.54B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $3.44B 10-K · filed 2025-02-26 | |
| 2023-09-30 | $3.25B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $3.01B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.78B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.61B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $2.57B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.59B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $2.50B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $2.61B 10-K · filed 2023-03-01 | |
| 2021-09-30 | $2.63B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.95B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.17B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $2.84B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $2.56B 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $2.30B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.52B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.63B 10-K · filed 2021-02-23 | |
| 2019-09-30 | $1.52B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.37B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.31B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.23B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $1.46B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.31B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.13B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $968.28M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $830.94M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $662.50M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $752.85M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $748.07M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $744.23M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.23B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.27B 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.26B 10-K · filed 2017-02-28 | |
| 2015-09-30 | $1.31B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.24B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.10B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.02B 10-K · filed 2016-02-23 | |
| 2014-09-30 | $878.52M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $544.91M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $517.32M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $864.62M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $810.07M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $734.18M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $647.37M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $551.57M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $385.01M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $300.44M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $327.14M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $199.13M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $152.14M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $136.09M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $74.46M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |